Literature DB >> 9193009

Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

M C Corti1, J M Guralnik, M E Salive, L Ferrucci, M Pahor, R B Wallace, C H Hennekens.   

Abstract

The association between iron levels and coronary artery disease (CAD) mortality is controversial. Whereas most data show no association, some have raised the possibility of a causal role, while others have suggested a protective effect of iron on CAD. To address these possibilities, we examined the association between serum iron and CAD, cardiovascular disease, and all-cause mortality in a large cohort of 3,936 persons aged > or =71 years who completed an interview, had a serum iron determination, and survived at least 1 year after baseline. The median follow-up time was 4.4 years. Serum iron levels were categorized according to sex-specific quartiles. Relative risks (RR) and 95% confidence intervals (CI) were calculated from proportional-hazards regression models adjusted for age, race, education, creatinine, serum albumin, serum lipids, use of iron supplementation, smoking, use of alcohol, blood pressure, body mass index, and presence of chronic conditions. There was a gradual decrease in the RRs of CAD, cardiovascular disease, and all-cause mortality with increasing serum iron levels (all tests for trend, p <0.05). Men in the highest iron quartile were one fifth as likely to die of CAD as men in the lowest iron quartile (RR 0.22; 95% CI 0.11 to 0.48), and women in the highest quartile had half the risk of women in the lowest quartile (RR 0.48; 95% CI 0.27 to 0.87). When compared with the lowest quartile, risk of all-cause mortality was 38% lower in men in the highest iron quartile (RR 0.62; 95% CI 0.46 to 0.85) and 28% lower in women in the highest quartile (RR 0.72; 95% CI 0.53 to 0.96). Results of similar strength and magnitude were observed for cardiovascular disease mortality and in analyses that excluded the first 3 years of follow-up. In this large cohort of persons aged > or =71 years, there was consistent evidence of increasing risk of mortality at lower serum iron levels. In fact, lower serum iron levels were associated with an increased risk of CAD, cardiovascular disease, and all-cause mortality. The results are compatible with the possibility that in an older population, there is an inverse association between serum iron levels and risk of mortality.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9193009     DOI: 10.1016/s0002-9149(96)00697-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

2.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies.

Authors:  Jacob Hunnicutt; Ka He; Pengcheng Xun
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

3.  Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.

Authors:  Odilson M Silvestre; Alexandra Gonçalves; Wilson Nadruz; Brian Claggett; David Couper; John H Eckfeldt; James S Pankow; Stefan D Anker; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-12-14       Impact factor: 15.534

4.  Financial difficulty in acquiring food among elderly disabled women: results from the Women's Health and Aging Study.

Authors:  L M Klesges; M Pahor; R I Shorr; J Y Wan; J D Williamson; J M Guralnik
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Total mortality risk in relation to use of less-common dietary supplements.

Authors:  Gaia Pocobelli; Alan R Kristal; Ruth E Patterson; John D Potter; Johanna W Lampe; Ann Kolar; Ilonka Evans; Emily White
Journal:  Am J Clin Nutr       Date:  2010-04-21       Impact factor: 7.045

6.  The Association of Opium Abuse with Mortality Amongst Hospitalized COVID-19 Patients in Iranian Population.

Authors:  Alireza Mirahmadizadeh; Alireza Heiran; Amineh Dadvar; Mohammad Javad Moradian; Mohammad Hossein Sharifi; Roya Sahebi
Journal:  J Prev (2022)       Date:  2022-06-02

7.  Evaluation of the Effects of Aging on the Aorta Stiffness in Relation with Mineral and Trace Element Levels: an Optimized Method via Custom-Built Stretcher Device.

Authors:  Duygu Aydemir; Naveed Salman; Mehrdad Karimzadehkhouei; B Erdem Alaca; Belma Turan; Nuriye Nuray Ulusu
Journal:  Biol Trace Elem Res       Date:  2020-09-12       Impact factor: 3.738

Review 8.  Non transferrin bound iron: nature, manifestations and analytical approaches for estimation.

Authors:  Meghna Patel; D V S S Ramavataram
Journal:  Indian J Clin Biochem       Date:  2012-08-31

Review 9.  Iron: protector or risk factor for cardiovascular disease? Still controversial.

Authors:  Carlos Muñoz-Bravo; Mario Gutiérrez-Bedmar; Jorge Gómez-Aracena; Antonio García-Rodríguez; Joaquín Fernández-Crehuet Navajas
Journal:  Nutrients       Date:  2013-07-01       Impact factor: 5.717

10.  Iron status and survival in diabetic patients with coronary artery disease.

Authors:  Beata Ponikowska; Tomasz Suchocki; Bartlomiej Paleczny; Martyna Olesinska; Slawomir Powierza; Ludmila Borodulin-Nadzieja; Krzysztof Reczuch; Stephan von Haehling; Wolfram Doehner; Stefan D Anker; John G F Cleland; Ewa A Jankowska
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.